3Gunn M, Stephens J, Thompson J, et al. Significant association of CagA positive Helicobacter pylori strains with risk of premature myocardial infarction. Heart, 2000, 84 : 267-271.
4Zentilin P, Seriolo B, Dulbecco P, et al. Eradication of Helicobacter pylori may reduce disease severity in rheumatoid arthritis. Aliment Pharmacol Ther,2002, 16 : 1291-1299.
5NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in peptic ulcer disease. JAMA, 1994,272:65-69.
6Versalovic JD, Shortridge K, Kibler MV ,et at. Mutation in 23S rRNA are associated with clarithromycin resistance in Hehcobacter pylori. Antimicrob Agents Chemther, 1996, 40:477-480.
7Matsuoka M, Yoshida Y, Hayakawa K, et al. Simultaneous colonization of Helicobacter pylori with and without mutations in the 23S rRNA gene in patients with no history of clarithromycin exposure. Gut, 1999, 45:503-507.
8Megraud F, Lehn N, Lind T, et al. Antimicrobial susceptibility testing of Helicobacter pylori in a large muhicenter trial: the MACH 2 study. Antimicrob Agents Chemther,1999,43:2747-2752.
9Megraud F. Resistance of Hehcobacter pylori to antibiotics. Aliment Pharmacol Ther, 1997,11:43-53.
10Loren L, Richard H, Hala EZ, et al. Bismuth-based quadruple therapy using a single capsule of Bismuth biskalcitrate, metronidazole and tetracycIine given with omeprazole versus omeprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a prospective, randomized, multicenter, North American trial. Am J Gastroenterol, 2003, 98:562-567.
6Hooi M, David S, Keivan A, et al. Anti-inflammatory, gastroprotec- tive and anti-ulcerogenic effects of red algae Gracilaria changii (Gracilariales, Rhodophyta) extract. [ J]. BMC Complement Altern Med ,2013,1 ( 13 ) :61 - 63.
7Steven G, Kinsey Laura E, Wise Divya, et al. Repeated low-dose ad- ministration of the monoacylglycerol lipase inhibitor JZL184 retains cannabinoid receptor type 1-mediated antinociceptive and gastroprotcc- tive effects[ J]. J Pharmacol Exper Ther,2013,345 (3) :492 - 501.
8Makarem M, Saeed Nadia A, Khalil Eman M, et al. Synthesis and anti-inflammatory activity of novel pyridazine and pyridazinone deriva- tives as non-ulcerogenic agents[ J ]. Arch Pharm Res,2012,35 (12) : 2077 - 2092.
9Liu J, Liu H, Zhang T, et al. Serum Helicobacter pylori Na- pA antibody as a potential biomarker for gastric cancer[ J]. Sci Rep ,2014 ,4 :4143.
10Poplawski T, Chojnacki C, Czubatka A, et al. Helicobacter pylori infection and antioxidants can modulate the genotoxic effects of heterocyclic amines in gastric mucosa cells [ J ]. Mol Biol Rep,2013,40 ( 8 ) : 1-8.
